<DOC>
	<DOCNO>NCT01849367</DOCNO>
	<brief_summary>Transcranial direct current stimulation ( tDCS ) novel treatment approach depression show promising efficacy four recent double-blind , randomize , sham-controlled trial ( RCT ) meta-analysis . Mood , cognitive test performance biomarkers measure trial .</brief_summary>
	<brief_title>Trial Bilateral tDCS Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>1 . Participant meet criterion DSMIV Major Depressive episode . 2 . MADRS score 20 . 1 . Diagnosis ( defined DSMIV ) : psychotic disorder ( lifetime ) ; eat disorder ( current within past year ) ; obsessive compulsive disorder ( lifetime ) ; posttraumatic stress disorder ( current within past year ) ; mental retardation . 2 . History drug alcohol abuse dependence ( per DSMIV criterion ) within last 3 month ( except nicotine caffeine ) . 3 . Inadequate response ECT current episode depression . 4 . Participant regular benzodiazepine medication clinically appropriate discontinue . 5 . Participant require rapid clinical response due inanition , psychosis high suicide risk . 6 . Neurological disorder insult , e.g. , recent stroke ( CVA ) , place participant risk seizure neuronal damage tDCS . 7 . Participant metal cranium , skull defect , skin lesion scalp ( cut , abrasion , rash ) propose electrode site . 8 . Female participant pregnant , childbearing age , sexually active use reliable contraception ( urine test pregnancy use ) . 9 . Participants fluent English include trial safety reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>